Charles River Laboratories | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Agilent USD 410M 16M 2025-01
Align Technology USD 424.97M 9.17M 2024-12
Bio-Rad Laboratories USD 199.7M 740K 2024-12
Bruker USD 247.3M 17.4M 2024-12
Cardinal Health USD 1.31B 29M 2024-12
Charles River Laboratories USD 188.26M 946K 2024-12
Cigna USD 3.77B 254M 2024-12
CVS Health USD 10.52B 22M 2024-12
Danaher USD 2.02B 185M 2024-12
Dentsply International USD 375M 13M 2024-12
Elevance Health USD 10.74B 376M 2024-12
Galapagos EUR 41.25M 11.98M 2024-12
Hologic USD 265M 15.8M 2024-12
Humana 3.97B 631M 2024-12
Illumina USD 263M 29M 2024-12
Incyte USD 326.71M 17.5M 2024-12
IQVIA Holdings USD 453M 69M 2024-12
Laboratory Of America USD 595.2M 26.6M 2024-12
McKesson USD 2.03B 475M 2024-12
Merck EUR 1.05B 361M 2024-12
Mettler Toledo International USD 237.34M 8.56M 2024-12
Novartis USD 3.5B 368M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Quest Diagnostics USD 466M 34M 2024-12
Revvity USD 255.62M 23.46M 2024-12
Thermo Fisher Scientific USD 2.21B 114M 2024-12
United Therapeutics USD 162.5M 8.4M 2024-12
UnitedHealth USD 13.59B 1.1B 2025-03
Walgreens Boots Alliance USD 8.89B 2.36B 2025-02
Waters USD 173.27M 4.17M 2024-12
West Pharmaceutical Services USD 85.3M 1.8M 2024-12



Charles River Laboratories Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.